CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,012,656 | -27.0% | 1,027,601 | -16.1% | 0.00% | -25.0% |
| Q2 2023 | $16,458,813 | -12.5% | 1,224,614 | +7.9% | 0.00% | -20.0% |
| Q1 2023 | $18,815,780 | -29.7% | 1,134,848 | -21.1% | 0.01% | -37.5% |
| Q4 2022 | $26,750,539 | +40.8% | 1,438,201 | -2.9% | 0.01% | +33.3% |
| Q3 2022 | $19,000,000 | +184.3% | 1,480,909 | +55.4% | 0.01% | +200.0% |
| Q2 2022 | $6,682,000 | +70.2% | 953,262 | +101.3% | 0.00% | +100.0% |
| Q1 2022 | $3,925,000 | +1502.0% | 473,497 | +1206.2% | 0.00% | – |
| Q4 2021 | $245,000 | +17.2% | 36,250 | -8.2% | 0.00% | – |
| Q3 2021 | $209,000 | +5.6% | 39,481 | +14.9% | 0.00% | – |
| Q2 2021 | $198,000 | +38.5% | 34,362 | +10.5% | 0.00% | – |
| Q1 2021 | $143,000 | +20.2% | 31,105 | -12.7% | 0.00% | – |
| Q4 2020 | $119,000 | +41.7% | 35,620 | +25.8% | 0.00% | – |
| Q3 2020 | $84,000 | -56.7% | 28,316 | -32.4% | 0.00% | – |
| Q2 2020 | $194,000 | +74.8% | 41,910 | +44.6% | 0.00% | – |
| Q1 2020 | $111,000 | +44.2% | 28,984 | +40.2% | 0.00% | – |
| Q4 2019 | $77,000 | -96.3% | 20,673 | -94.8% | 0.00% | -100.0% |
| Q3 2019 | $2,094,000 | +4173.5% | 394,346 | +1437.3% | 0.00% | – |
| Q4 2018 | $49,000 | -51.5% | 25,652 | -3.6% | 0.00% | – |
| Q3 2018 | $101,000 | +13.5% | 26,598 | -6.9% | 0.00% | – |
| Q2 2018 | $89,000 | -91.2% | 28,558 | -93.1% | 0.00% | – |
| Q4 2015 | $1,014,000 | -18.1% | 413,770 | +0.2% | 0.00% | -100.0% |
| Q3 2015 | $1,238,000 | +20533.3% | 412,753 | +29766.4% | 0.00% | – |
| Q2 2015 | $6,000 | -96.5% | 1,382 | -97.9% | 0.00% | – |
| Q2 2014 | $171,000 | – | 67,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |